Clearmind MedicineCMND
13F holders, Q2 2024 (June 30)4holders
1new positions
1sold out
$1.66avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Clearmind Medicine Inc. (CMND) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were AdvisorShares Investments LLC ($214K), Cornerstone Wealth Group, LLC ($34K) and Geode Capital Management, LLC ($28K).
- Company
- Clearmind Medicine Inc.
- CUSIP
- 185053402
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $34K |
| Exits | 1 | $27K |
All 13F filers, Q1 2024 → Q2 2024: 36,300 shares bought and 23,981 shares sold, net +12,319 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| AdvisorShares Investments LLC | 0.04% | Add +14.2% | 128,641 | $214K |
| Cornerstone Wealth Group, LLC | 0.00% | New | 20,000 | $34K |
| Geode Capital Management, LLC | 0.00% | Add +2.2% | 16,586 | $28K |
| Royal Bank of Canada | 0.00% | No change | 569 | $1K |
"% of holder's portfolio" is CMND's weight in each manager's 13F, not the share of Clearmind Medicine Inc. the manager owns.